Work

Case Report “Tenofovir Alafenamide Induced Alopecia in a Zambian Teenager”

Year: 2021

Type: article

Abstract: Adverse drug reactions continue to pose a global risk in the fight against HIV. In an attempt to attain end the AIDS pandemic by 2030, newer drugs are being formulated with better efficacy and fewer side effects. However, these new drugs still have Adverse Drug Reactions (ADRs) which may affect adherence and compliance. We present a rare case of Tenofovir Alafenamide (TAF) induced alopecia of a Zambian teenager in the context of pharmacovigilance as a tool to identify ADRs which may or may not Have been identified during clinical trials. This is a wake-up call to all health care workers to identify and report ADRs and use the established channels to affect policy change.

Source: Medical Journal of Zambia

DOI: 10.55320/mjz.48.1.726

Authors: Jean Mwanamwalye Mukumbuta, Benedict Moonga, Malan Malumani

Institution: Livingstone Hospital

Language: English

Topic: HIV/AIDS drug development and treatment

Subfield: Infectious Diseases

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: diamond

OpenAlex ID: W4313045252

FWCI:

Cites:

Cited by:

Related to: 10